Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of BridgeBio Pharma ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Analysts at Leerink Partnrs upped their FY2024 EPS estimates for Mirum Pharmaceuticals in a research report issued to clients ...

In a challenging year for biotechnology firms, PureTech Health PLC (PRTC) stock has touched a 52-week low, dipping to $16.81.

In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Castle Biosciences (CSTL – Research Report) yesterday and set a price target ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 17.88% ...

Walgreens Boots Alliance Inc (WBA) stock saw a modest uptick, ending the day at $11.87 which represents a slight increase of $0.13 or 1.11% from the prior close of $11.74. The stock opened at $11.65 ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...